N-glycosylation-defective IL6 activates the SRC-YAP-SOX2 signaling to potentiate metastasis and TKI resistance in NSCLCCANCER RESEARCHIF16.62023-04-040PRE
Stat3 feedback activation-induced PTGIS expression is associated with acquired resistance to EGFR-TKI in lung cancerCANCER RESEARCHIF16.62017-07-010PRE
IL-6 dynamics regulate neuroendocrine transformation in gefitinib acquired resistance EGFR mutant lung cancer cellsCANCER RESEARCHIF16.62017-07-010PRE
IL-6 glycoforms differentially modulate the polarization of tumor-associated macrophages in lung cancerCANCER RESEARCHIF16.62016-07-150PRE
FTY720 inhibits mutant Kras-induced lung cancer via disrupting Stat3-S1PR1 vicious cycle and downregulating tumor PD-L1 expressionCANCER RESEARCHIF16.62014-10-010PRE
N-glycosylation on lung cancer cell-secreted IL-6 prolongs its activation on JAK/STAT pathwayCANCER RESEARCHIF16.62014-10-011PRE
Mitochondrial uncoupling protein 2 regulates the effects of paclitaxel on Stat3 activation and cellular survival in lung cancer cellsCARCINOGENESISIF2.92012-07-2242PREAI
Metformin enhances cisplatin cytotoxicity of lung cancer through Stat3 pathwayCANCER RESEARCHIF16.62012-04-010PRE